Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA. Grellety T, Peyraud F, Sevenet N, Tredan O, et al. Ann Oncol 2020 Mar 17. pii: S0923-7534(20)36362.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grellety T, Peyraud F, Sevenet N, Tredan O, et al. Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA. Ann Oncol 2020 Mar 17. pii: S0923-7534(20)36362.
PMID: 32194151